ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report.

Maryam Fouladi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.